12/31/2024 3:24 PM | Assembly Biosciences (Issuer) Houghton Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2024 7:25 AM | Assembly Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/23/2024 7:17 PM | Assembly Biosciences (Subject) GILEAD SCIENCES, INC. (Filed by)
| Form SCHEDULE 13D/A | |
12/23/2024 7:26 PM | Assembly Biosciences (Issuer) GILEAD SCIENCES, INC. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/23/2024 4:34 PM | Assembly Biosciences (Subject) Schornstein Alexander (Filed by)
| Form SCHEDULE 13G/A | |
12/23/2024 10:59 AM | Assembly Biosciences (Subject) Schornstein Alexander (Filed by)
| Form SCHEDULE 13G | |
12/19/2024 7:05 AM | Assembly Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/26/2024 8:15 AM | Assembly Biosciences (Issuer) Schornstein Alexander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2024 2:22 PM | ARMISTICE CAPITAL, LLC (Filed by) Assembly Biosciences (Subject)
| Form SC 13G | |
11/07/2024 3:42 PM | Assembly Biosciences (Filer)
| Form 424B5 | |
11/07/2024 3:50 PM | Assembly Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ASMB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Assembly Biosciences and its competitors with MarketBeat's FREE daily newsletter.
|
11/07/2024 3:24 PM | Assembly Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/09/2024 8:15 AM | Assembly Biosciences (Issuer) Schornstein Alexander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2024 3:05 PM | Assembly Biosciences (Issuer) Okazaki Jason A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2024 3:05 PM | Assembly Biosciences (Issuer) White Nicole S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/23/2024 7:05 AM | Assembly Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/08/2024 9:48 AM | Assembly Biosciences (Issuer) Schornstein Alexander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 3:28 PM | Assembly Biosciences (Subject) Schornstein Alexander (Filed by)
| Form SC 13D/A | |
06/20/2024 7:31 PM | Assembly Biosciences (Issuer) GILEAD SCIENCES, INC. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 7:35 PM | Assembly Biosciences (Subject) GILEAD SCIENCES, INC. (Filed by)
| Form SC 13D/A | |
05/24/2024 3:05 PM | Assembly Biosciences (Issuer) Okazaki Jason A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 3:05 PM | Assembly Biosciences (Issuer) White Nicole S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/08/2024 3:15 PM | Assembly Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/01/2024 3:05 PM | Assembly Biosciences (Issuer) Delaney William E IV (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/01/2024 3:05 PM | Assembly Biosciences (Issuer) Okazaki Jason A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:15 PM | Assembly Biosciences (Filer)
| Form DEFA14A | |
04/02/2024 3:25 PM | Assembly Biosciences (Issuer) McHutchison John G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 3:15 PM | Assembly Biosciences (Issuer) White Nicole S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2024 3:10 PM | Assembly Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/15/2024 3:10 PM | Assembly Biosciences (Issuer) Cook Robert Donald II (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |